AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Sale
+$1,911,000
-16.55%
Shares
Shares Volume: 100,000 Shares
Average Share Price: $19.11
INSIDER
Zakrzewski Joseph S
Director
reported on Jan 19 2024
traded on Jan 18 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 504,079 |
| PURCHASES/SALES 1Y | 0 / 1 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,911,000 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 5 |
| PURCHASES/SALES 1Y | 2 / 36 |
| P/S VALUE RATIO | 1.572 |
| AVERAGE SALE VALUE | $283,740.32 |
| COMPANY PREVIOUS TRADES |